REBECCA TOMPKINS: Open Payments
NPI 1528248168 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,129 in 109 payments from 18 companies in 2025. Trend: 2023 $497 · 2024 $1,519 · 2025 $2,129
Food & beverage: $2,129
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 14 | $384 |
| PFIZER INC. | 18 | $307 |
| ABBVIE INC. | 19 | $252 |
| Novartis Pharmaceuticals Corporation | 22 | $236 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $234 |
| Regeneron Healthcare Solutions, Inc. | 3 | $164 |
| Arcutis Biotherapeutics, Inc. | 2 | $153 |
| UCB, Inc. | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $62 |
| Incyte Corporation | 3 | $59 |
Products named: NEMLUVIO, CIBINQO, Winlevi, Zoryve, LIBTAYO, SKYRIZI, RINVOQ, COSENTYX.
Industry payments across IN — which companies pay providers there.
